Evidence map›Paper›PMID 35999577›Full record

ReviewAdvances in rheumatology (London, England)2022

Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review.

Cristina Hidalgo Calleja, Daniel Martín Hidalgo, Concepción Román Curto, Lourdes Vázquez López, Estefanía Pérez López, Mónica Cabrero Calvo, Ana África Martín López, María Dolores Caballero Barrigón, Lucía Lopez-Corral

Open access · diamondAbstract readReview
PubMed Publisher
In one paragraph

Review in Advances in rheumatology (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Eosinophilic fasciitis.Medicina clinica · 2025
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Cristina Hidalgo CallejaRheumatology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Paseo de San Vicente 58-182, 37007, Salamanca, Spain. chidalgoc15@gmail.com.ORCID 0000-0001-5505-7539
Daniel Martín HidalgoFamily and Community Medicine Training Programme, Hospital Universitario Río Hortega, Valladolid, Spain.
Concepción Román CurtoDermatology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain.
Lourdes Vázquez LópezHaematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.
Estefanía Pérez LópezHaematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.
Mónica Cabrero CalvoHaematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.
Ana África Martín LópezHaematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.
María Dolores Caballero BarrigónHaematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.
Lucía Lopez-CorralHaematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.
Instituto de Investigación Biomédica de Salamanca · ESComplejo Hospitalario de Salamanca · ESHospital Universitario Río Hortega · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic graft versus host disease (cGVHD) simulating eosinophilic fasciitis (EF) is an underdiagnosed and challenging complication due to the lack of knowledge about its pathogenesis, refractoriness to traditional immunosuppressive agents and their negative impact on the physical function and quality of life. The aim of this study is to describe the clinical-biological characteristics and response to treatment of a case series and to provide a comprehensive literature review on cGVHD related EF involvement.

methodsProspective observational study to describe the clinical and diagnostic evaluation characteristics of patients with EF-like follow-up as part of our multidisciplinary cGVHD consultations. In addition, the literature on joint and/or fascial musculoskeletal manifestations due to cGVHD was comprehensively reviewed.

results118 patients were evaluated in multidisciplinary cGVHD consultations, 39 of whom (33%) developed fasciitis. Notably, 11 patients had isolated joint contractures without sclerotic skin. After a median of three lines of treatment, the vast majority of patients achieved some degree of response. 94 potentially eligible articles were identified by the search strategy, with 17 of them, the majority isolated case reports, making the final selection. The validated staging scales used for the assessment were the Joint and Fascial Score and the Photographic Range of Motion.

conclusionFascial/articular involvement needs to be recognized and evaluated early. To our knowledge, our cohort is the second largest series to have been reported. Literature addressing fascial/joints complications related to cGVHD is scarce. The search for new biomarkers, the use of advanced imaging techniques and multidisciplinary approach may help improve the prognosis of patients with cGVHD.

Indexed as

FasciitisGraft vs Host DiseaseHematopoietic Stem Cell TransplantationEosinophiliaHumansObservational Studies as TopicQuality of LifeAllogeneic stem cell transplantationChronic graft versus host diseaseFasciitisJoint contractureSclerosis

Identifiers

PMID35999577
OpenAlexW4292702936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.